A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C.
What to Expect from a Potential Trump Administration in 2025
As Donald Trump campaigns for a potential return to the presidency, speculation grows about what his administration might prioritize and how it would shape the